Price Charts

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2065.600.2 (+0.01 %)
PREV CLOSE ( ) 2065.40
OPEN PRICE ( ) 2070.10
BID PRICE (QTY) 2067.35 (17)
OFFER PRICE (QTY) 2069.00 (6)
VOLUME 854
TODAY'S LOW / HIGH ( )2056.60 2075.35
52 WK LOW / HIGH ( )1228 2649.95
NSE2065.900.3 (+0.01 %)
PREV CLOSE( ) 2065.60
OPEN PRICE ( ) 2073.90
BID PRICE (QTY) 2063.85 (13)
OFFER PRICE (QTY) 2066.00 (10)
VOLUME 19447
TODAY'S LOW / HIGH( ) 2053.00 2078.50
52 WK LOW / HIGH ( )1227 2524
Plot at :
Compare with :
Select Period :
Glaxosmithkline Pharmaceuticals Ltd.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.